Literature DB >> 30334576

Enasidenib-induced eosinophilic differentiation in a patient with acute myeloid leukaemia with IDH2 and U2AF1 mutations.

Jonathan Galeotti1, Catherine C Coombs2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30334576     DOI: 10.1111/bjh.15609

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   8.615


× No keyword cloud information.
  1 in total

1.  Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.

Authors:  Steven Ngo; Ethan P Oxley; Margherita Ghisi; Maximilian M Garwood; Mark D McKenzie; Helen L Mitchell; Peter Kanellakis; Olivia Susanto; Michael J Hickey; Andrew C Perkins; Benjamin T Kile; Ross A Dickins
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.